Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer

by Daniel L. Hertz, Karen Lisa Smith, Yuhua Zong, Christina L. Gersch, Andrea M. Pesch, Jennifer Lehman, Amanda L. Blackford, N. Lynn Henry, Kelley M. Kidwell, James M. Rae, Vered Stearns
Published 2021-06-01